- Home
- EPOW vs OVID Comparison
EPOW vs OVID Comparison
Compare EPOW & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- OVID
- Stock Information
- Founded
- EPOW 2014
- OVID 2014
- Country
- EPOW China
- OVID United States
- Employees
- EPOW N/A
- OVID N/A
- Industry
- EPOW Business Services
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- EPOW Consumer Discretionary
- OVID Health Care
- Exchange
- EPOW Nasdaq
- OVID Nasdaq
- Market Cap
- EPOW 27.0M
- OVID 24.0M
- IPO Year
- EPOW 2021
- OVID 2017
- Fundamental
- Price
- EPOW $0.91
- OVID $0.29
- Analyst Decision
- EPOW
- OVID Strong Buy
- Analyst Count
- EPOW 0
- OVID 6
- Target Price
- EPOW N/A
- OVID $3.03
- AVG Volume (30 Days)
- EPOW 18.2K
- OVID 385.5K
- Earning Date
- EPOW 05-27-2025
- OVID 05-13-2025
- Dividend Yield
- EPOW N/A
- OVID N/A
- EPS Growth
- EPOW N/A
- OVID N/A
- EPS
- EPOW N/A
- OVID N/A
- Revenue
- EPOW $46,625,085.00
- OVID $548,000.00
- Revenue This Year
- EPOW N/A
- OVID N/A
- Revenue Next Year
- EPOW N/A
- OVID $36.11
- P/E Ratio
- EPOW N/A
- OVID N/A
- Revenue Growth
- EPOW N/A
- OVID 15.61
- 52 Week Low
- EPOW $0.53
- OVID $0.24
- 52 Week High
- EPOW $1.36
- OVID $3.43
- Technical
- Relative Strength Index (RSI)
- EPOW 44.49
- OVID 42.88
- Support Level
- EPOW $0.87
- OVID $0.29
- Resistance Level
- EPOW $0.96
- OVID $0.33
- Average True Range (ATR)
- EPOW 0.06
- OVID 0.03
- MACD
- EPOW -0.01
- OVID 0.00
- Stochastic Oscillator
- EPOW 33.33
- OVID 22.36
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is into the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.